Why the study?
Does bepridil improve conversion to and maintenance of sinus rhythm in patients with persistent atrial fibrillation?
Does bepridil improve conversion to and maintenance of sinus rhythm in patients with persistent atrial fibrillation?
Bepridil is an effective antiarrhythmic agent for restoring and maintaining sinus rhythm in persistent atrial fibrillation, provided that rigorous monitoring for QT prolongation and interstitial pneumonia is maintained.
Answers are grounded in this paper and cite their sources.
May support bepridil for persistent AF conversion with QT/pneumonia monitoring; leaves open randomized confirmation of dose efficacy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yuji Nakazato (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: